UC San Francisco researchers received six awards announced in October by the National Institutes of Health (NIH) for high-risk, high-reward scientific research projects. Their work will focus on novel approaches for diagnosing and treating diseases ranging from autoimmune and chronic inflammatory diseases, to cancer, diabetes and neurological disorders. Glenn-Milo Santos, PhD who is among the first graduates of UCSF's Epidemiology & Translational Science PhD program is an awardee of the NIH Director’s Early Independence Award.
UC San Francisco (UCSF) is working to create an online platform that health workers around the world can use to predict where malaria is likely to be transmitted using data on Google Earth Engine.
The goal is to enable resource poor countries to wage more targeted and effective campaigns against the mosquito-borne disease, which kills 600,000 people a year, most of them children.
It is estimated that 25-50% of men may be over-treated for their prostate cancer. This means they undergo treatments that incur adverse effects (e.g. erectile dysfunction, incontinence) for a cancer that is not likely to spread during their lifetime. Active surveillance is an alternative option for patients when the prostate biopsy indicates their cancer is unlikely to spread quickly. However, in as many as 30 percent of cases, the cancer may turn out to be more aggressive than it initially appeared at the time of diagnosis.